1-3 of 3
Ahmad Absi
Close
Sort by
Journal Articles

Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)

Tarek Abouzeid, Taimoor Hussain, Sameer AlAmoudi, Ahmad Absi, Arif Alam, Mansour Alfayez, Ahmad Alhuraiji, Mohammed Aldarweesh, Husni Al-Hateeti, Gehad El Ashal, Omar Hussein, Ali Anwar, Mohamed Gouda Ismail, Leila Bereksi, Haidy Abdellatif, Yasser Nour, Abdallah Saad, Naeem A. Chaudhri
Journal: Blood
Blood (2022) 140 (Supplement 1): 12397–12399.
https://doi.org/10.1182/blood-2022-168049
Published: 2022
Journal Articles

The Outcome of Diffuse Large B-Cell Lymphoma with CNS Involvement at Diagnosis, Single-Center Experience

Mubarak A Almansour, MD, Saif Saif, Ziyad Alhrbi, Abdulrhamn Alhwaity, Ahmed Almasrahi, Waleed Alnejadi, Mohammed anwar Khan, Sarah surur Hussain, Ahmad Absi
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-140344
Published: 2020
Journal Articles

Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City - Jeddah - KSA Experience

Muteb Althomali, Ahmad Absi, Ihab El Hemaidi, Ashraf Warsi, Sameer AlAmoudi, Majed Alahmadi, Walaa Rajkhan, Sultan Almutairi, Saleem Eldadah, Manar Khalil, Muna Adam, Syed Adnaan Ali, Abdulrahman Alghamdi, Ahmad Alsaeed
Journal: Blood
Blood (2019) 134 (Supplement_1): 5295.
https://doi.org/10.1182/blood-2019-121993
Published: 2019